Guidelines for the management of an elevated INR [A1]
General points
· Bleeding risk increases exponentially from INR 5 to 9.
· Any INR≥6 requires close monitoring, for example daily INR if no active bleeding until INR <5
· It takes 6-12 hours for vitamin K to reduce the INR
· See the table below to guide therapy for an elevated INR
· *High bleeding risk patients include
o active gastrointestinal disorders (e.g. peptic ulcer disease, inflammatory bowel disease)
o concomitant antiplatelet (eg aspirin, clopidogrel) or anticoagulation (eg enoxaparin/heparin) therapy
o major surgical procedure in preceeding two weeks
o Low platelet count (<50)
· In all situations, carefully reassess the need for ongoing anti-coagulation therapy
o The use of anticoagulants is based on an assessment of relative thrombotic and bleeding risk. After every serious bleed, reassessment is required and a decision to stop anticoagulation may be appropriate in some patients. If you have any queries about this please discuss with a haematologist.
o Recurrence rates after major bleeds are 30 – 50%.
o Consider aspirin as a safer alternative in patients with AF who have a major bleed.
o In patients who need to have warfarin continued, closer monitoring of the INR is required to avoid future episodes of over-anticoagulation.
Guide to the management of over-anticoagulation with warfarin
INR <5 Bleeding absent |
|
INR 5-9 Bleeding absent |
|
INR >9 Bleeding absent |
Low bleeding risk
*High bleeding risk
|
Any clinically significant bleeding |
If FFP unavailable, use 25-50 IU/kg prothrombinex if prothrombinex unavailable, use 10-15mL/kg fresh frozen plasma |
· Click here to link to the
o Duration and Intensity of Anti-coagulation section of the guidelines
o Risk Factors for Bleeding section of the guidelines